BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17295416)

  • 1. Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery.
    Chen G; Pramanik BN; Liu YH; Mirza UA
    J Mass Spectrom; 2007 Mar; 42(3):279-87. PubMed ID: 17295416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS for protein characterization: current capabilities and future trends.
    Chen G; Pramanik BN
    Expert Rev Proteomics; 2008 Jun; 5(3):435-44. PubMed ID: 18532911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
    Srebalus Barnes CA; Lim A
    Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data pre-processing in liquid chromatography-mass spectrometry-based proteomics.
    Zhang X; Asara JM; Adamec J; Ouzzani M; Elmagarmid AK
    Bioinformatics; 2005 Nov; 21(21):4054-9. PubMed ID: 16150809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of LC/MS to proteomics studies: current status and future prospects.
    Chen G; Pramanik BN
    Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A geometric approach for the alignment of liquid chromatography-mass spectrometry data.
    Lange E; Gröpl C; Schulz-Trieglaff O; Leinenbach A; Huber C; Reinert K
    Bioinformatics; 2007 Jul; 23(13):i273-81. PubMed ID: 17646306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent applications of liquid chromatography-mass spectrometry in natural products bioanalysis.
    Xing J; Xie C; Lou H
    J Pharm Biomed Anal; 2007 Jun; 44(2):368-78. PubMed ID: 17317073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of regulatory molecular events and biomarkers using 2D capillary chromatography and mass spectrometry.
    Powell DW; Merchant ML; Link AJ
    Expert Rev Proteomics; 2006 Feb; 3(1):63-74. PubMed ID: 16445351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional turbulent flow chromatography coupled on-line to liquid chromatography-mass spectrometry for solution-based ligand screening against multiple proteins.
    Zhou JL; An JJ; Li P; Li HJ; Jiang Y; Cheng JF
    J Chromatogr A; 2009 Mar; 1216(12):2394-403. PubMed ID: 19203758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein glycosylation analysis by liquid chromatography-mass spectrometry.
    Wuhrer M; Deelder AM; Hokke CH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):124-33. PubMed ID: 16213446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC/MS applications in drug development.
    Lee MS; Kerns EH
    Mass Spectrom Rev; 1999; 18(3-4):187-279. PubMed ID: 10568041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.
    Xie H; Gilar M; Gebler JC
    Anal Chem; 2009 Jul; 81(14):5699-708. PubMed ID: 19518054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIPER: an advanced software package to support high-throughput LC-MS peptide identification.
    Monroe ME; Tolić N; Jaitly N; Shaw JL; Adkins JN; Smith RD
    Bioinformatics; 2007 Aug; 23(15):2021-3. PubMed ID: 17545182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides.
    Lin ZJ; Li W; Dai G
    J Pharm Biomed Anal; 2007 Jun; 44(2):330-41. PubMed ID: 17339091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron capture dissociation mass spectrometry in characterization of peptides and proteins.
    Bakhtiar R; Guan Z
    Biotechnol Lett; 2006 Jul; 28(14):1047-59. PubMed ID: 16794768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical prediction of protein chemical interactions based on chemical structure and mass spectrometry data.
    Nagamine N; Sakakibara Y
    Bioinformatics; 2007 Aug; 23(15):2004-12. PubMed ID: 17510168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
    Ma S; Zhu M
    Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.